Follow-up of NAFLD Patients With MRI-PDFF

NCT04910178 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Type 2
NAFLD

Interventions

DRUG: Empagliflozin 25 MG
DRUG: Ursodeoxycholic acid
DRUG: Pentoxifylline 400 MG
OTHER: placebo

Sponsor

Asmaa Abdelfattah Elsayed